[Antiglaucomatous therapy with reduced concentrations (author's transl)].
By reducing the concentration of hypotensive drops and increasing the number of instillations, a therapeutic effect similar to that of the concentrated drop can be obtained, with a reduction of side-effects. The results of experiments with pilocarpine, adrenaline-guanethidine combination and propranolol are described.
D004359:Drug Therapy, Combination; D004837:Epinephrine / Q000008:administration & dosage / Q000627:therapeutic use; D005901:Glaucoma / Q000188:drug therapy*; D006145:Guanethidine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D009883:Ophthalmic Solutions; D010862:Pilocarpine / Q000008:administration & dosage / Q000627:therapeutic use; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use
D009883:Ophthalmic Solutions; D010862:Pilocarpine; D011433:Propranolol; D004837:Epinephrine; D006145:Guanethidine
Thérapie antiglaucomateuse à concentration réduite.